Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Varghese

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
British Journal of Haematology|March 30, 2026
Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximabDavid J Allsup, David A Cairns, E Faye Samy, et al.
American Journal of Respiratory and Critical Care Medicine|April 26, 2024
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry PatientsTimothy R Aksamit, Nicholas Locantore, Doreen Addrizzo-Harris, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
British Journal of Haematology|March 30, 2026
Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximabDavid J Allsup, David A Cairns, E Faye Samy, et al.
American Journal of Respiratory and Critical Care Medicine|April 26, 2024
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry PatientsTimothy R Aksamit, Nicholas Locantore, Doreen Addrizzo-Harris, et al.
Pageof 3